Literature DB >> 16814106

Mitochondrial defects and oxidative damage in patients with peripheral arterial disease.

Iraklis I Pipinos1, Andrew R Judge, Zhen Zhu, Joshua T Selsby, Stanley A Swanson, Jason M Johanning, Bernard T Baxter, Thomas G Lynch, Stephen L Dodd.   

Abstract

Abnormal mitochondrial function is present in patients with peripheral arterial disease and may contribute to its clinical manifestations. However, the specific biochemical mitochondrial defects and their association with increased oxidative stress have not been fully characterized. Gastrocnemius muscle was obtained from peripheral arterial disease patients (n = 25) and age-matched controls (n = 16) and mitochondrial parameters were measured. Complexes I through IV of the electron transport chain were individually evaluated to assess for isolated defects. Muscle was also evaluated for protein and lipid oxidative changes by measuring the levels of protein carbonyls, lipid hydroperoxides, and total 4-hydroxy-2-nonenal binding and for the activities of the antioxidant enzymes superoxide dismutase, catalase, and glutathione peroxidase. Mitochondrial electron transport chain complexes I, III, and IV in arterial disease patients demonstrated significant reductions in enzymatic activities and mitochondrial respiration compared to controls. Oxidative stress biomarker analysis demonstrated significantly increased levels of protein carbonyls, lipid hydroperoxides, and 4-hydroxy-2-nonenal compared to control muscle. Antioxidant enzyme activities were altered, with a significant decrease in superoxide dismutase activity and significant increases in catalase and glutathione peroxidase. Peripheral arterial disease is associated with abnormal mitochondrial function and evidence of significant oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16814106     DOI: 10.1016/j.freeradbiomed.2006.04.003

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  91 in total

1.  Abnormal joint powers before and after the onset of claudication symptoms.

Authors:  Panagiotis Koutakis; Jason M Johanning; Gleb R Haynatzki; Sara A Myers; Nicholas Stergiou; G Matthew Longo; Iraklis I Pipinos
Journal:  J Vasc Surg       Date:  2010-08       Impact factor: 4.268

Review 2.  Models of accelerated sarcopenia: critical pieces for solving the puzzle of age-related muscle atrophy.

Authors:  Thomas W Buford; Stephen D Anton; Andrew R Judge; Emanuele Marzetti; Stephanie E Wohlgemuth; Christy S Carter; Christiaan Leeuwenburgh; Marco Pahor; Todd M Manini
Journal:  Ageing Res Rev       Date:  2010-05-14       Impact factor: 10.895

3.  Pharmacological treatment of intermittent claudication does not have a significant effect on gait impairments during claudication pain.

Authors:  Jennifer M Yentes; Jessie M Huisinga; Sara A Myers; Iraklis I Pipinos; Jason M Johanning; Nicholas Stergiou
Journal:  J Appl Biomech       Date:  2012-05       Impact factor: 1.833

4.  Exercise performance and peripheral vascular insufficiency improve with AMPK activation in high-fat diet-fed mice.

Authors:  Kristen A Baltgalvis; Kathy White; Wei Li; Mark D Claypool; Wayne Lang; Raniel Alcantara; Baljit K Singh; Annabelle M Friera; John McLaughlin; Derek Hansen; Kelly McCaughey; Henry Nguyen; Ira J Smith; Guillermo Godinez; Simon J Shaw; Dane Goff; Rajinder Singh; Vadim Markovtsov; Tian-Qiang Sun; Yonchu Jenkins; Gerald Uy; Yingwu Li; Alison Pan; Tarikere Gururaja; David Lau; Gary Park; Yasumichi Hitoshi; Donald G Payan; Todd M Kinsella
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-02-21       Impact factor: 4.733

5.  A low-cost, wireless near-infrared spectroscopy device detects the presence of lower extremity atherosclerosis as measured by computed tomographic angiography and characterizes walking impairment in peripheral artery disease.

Authors:  Matthew A Fuglestad; Hernan Hernandez; Yue Gao; Henamari Ybay; Molly N Schieber; Katyarina E Brunette; Sara A Myers; George P Casale; Iraklis I Pipinos
Journal:  J Vasc Surg       Date:  2019-08-21       Impact factor: 4.268

Review 6.  Exercise rehabilitation in peripheral artery disease: functional impact and mechanisms of benefits.

Authors:  Naomi M Hamburg; Gary J Balady
Journal:  Circulation       Date:  2011-01-04       Impact factor: 29.690

Review 7.  Functional impairment in peripheral artery disease and how to improve it in 2013.

Authors:  Mary McGrae McDermott
Journal:  Curr Cardiol Rep       Date:  2013-04       Impact factor: 2.931

8.  Joint torques and powers are reduced during ambulation for both limbs in patients with unilateral claudication.

Authors:  Panagiotis Koutakis; Iraklis I Pipinos; Sara A Myers; Nicholas Stergiou; Thomas G Lynch; Jason M Johanning
Journal:  J Vasc Surg       Date:  2009-10-17       Impact factor: 4.268

9.  The effect of pharmacological treatment on gait biomechanics in peripheral arterial disease patients.

Authors:  Jessie M Huisinga; Iraklis I Pipinos; Jason M Johanning; Nicholas Stergiou
Journal:  J Neuroeng Rehabil       Date:  2010-06-07       Impact factor: 4.262

Review 10.  Therapeutic Potential of Modulating MicroRNA in Peripheral Artery Disease.

Authors:  Naomi M Hamburg; Nicholas J Leeper
Journal:  Curr Vasc Pharmacol       Date:  2015       Impact factor: 2.719

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.